Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 4Withdrawn 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vasculitis, Central Nervous System 1Stiff-Person Syndrome 1Rasmussen subacute encephalitis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Plasmablastic Lymphoma 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lambert-Eaton Myasthenic Syndrome 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1Autoimmune Diseases of the Nervous System 1Autoimmune Diseases 1

Interventions

Nivolumab 10Doxorubicin 10Cyclophosphamide 10Vinblastine 9Radiotherapy 8Dacarbazine 8Brentuximab Vedotin 8Bleomycin 7fludarabine phosphate 6fludarabine 6Prednisone 6Etoposide 6pembrolizumab 5Melphalan 5Whole-Body Irradiation 4Vincristine 4Mycophenolic Acid 4Filgrastim 4Tacrolimus 3Radiation 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Thiotepa 2Sirolimus 2Procarbazine 2Mechlorethamine 2Bendamustine Hydrochloride 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hodgkin Disease × carmustine, poliferprosan 20 drug combination × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡